Sponsors

Silver sponsor - Genentech

Genentech pioneered the biotech industry and revolutionized how we treat some of the world’s most complex health problems. For nearly 50 years, they have pursued groundbreaking science to discover and develop innovative medicines for people facing serious and life-threatening diseases like MS.

Today, as a member of the Roche Group, they remain dedicated to pursuing breakthrough research, developing life-changing medicines, unlocking advances in data and technology, and partnering across society to advocate for better healthcare for all.

Their drug, Ocrevus, is the only therapy approved for both relapsing-remitting multiple sclerosis [RRMS] and active, secondary progressive multiple sclerosis [SPMS], as well as primary progressive multiple sclerosis (PPMS).